Subscribe To
ALBT / Avalon GloboCare investee LSM inks lab testing deal with GeneX
ALBT News
By Proactive Investors
October 4, 2023
Avalon GloboCare debuts KetoAir app on Apple App Store
Avalon GloboCare Corp (NASDAQ:ALBT) has officially unveiled its KetoAir mobile application on the Apple App Store. Coupled with an AI nutritionist and more_horizontal
By Proactive Investors
September 13, 2023
Avalon GloboCare shares spike on Laboratory Services MSO acquisitions
Avalon GloboCare Corp (NASDAQ:ALBT) announced that its 40% owned clinical diagnostics and reference lab Laboratory Services MSO (LSM) has made two si more_horizontal
By Proactive Investors
September 5, 2023
Avalon GloboCare shares surge as recent momentum continues
Avalon GloboCare Corp (NASDAQ:ALBT) shares climbed 29% to $1.24 on Tuesday after the precision diagnostics and clinical laboratory services provider more_horizontal
By Proactive Investors
September 5, 2023
Avalon GloboCare adds QTY Code patent to its portfolio
Avalon GloboCare Corp (NASDAQ:ALBT) has received a new patent to add to its portfolio. The Freehold, New Jersey-based company announced the United Sta more_horizontal
By Proactive Investors
August 30, 2023
Avalon GloboCare investee LSM launches innovative lab test for tuberculosis
Avalon GloboCare Corp (NASDAQ:ALBT) announced that its 40% owned Laboratory Services MSO, LLC (LSM) is now offering an in-house laboratory developed t more_horizontal
By Proactive Investors
July 24, 2023
Avalon GloboCare investee buys Houston-based lab testing facility
Avalon GloboCare Corp (NASDAQ:ALBT) announced that Laboratory Services MSO, in which the company holds a 40% interest, has acquired DE Laboratory LLC. more_horizontal
By Proactive Investors
July 19, 2023
Avalon GloboCare investee LSM inks lab testing deal with GeneX
Avalon GloboCare Corp (NASDAQ:ALBT) announced that its 40% owned Laboratory Services MSO, LLC (LSM) has signed an exclusive master service agreement ( more_horizontal
By Proactive Investors
July 10, 2023
Avalon GloboCare says 2023 will be ‘pivotal year' as it executes new commercial strategy
Avalon GloboCare Corp (NASDAQ:ALBT) has updated investors on its progress in implementing its new commercial strategy focused on laboratory acquisitio more_horizontal